Member Info for Retour_du_Renard

Let's hope they get an progress report out. We are due one. It's been a while.

WC - The point is though. Until the vote (or the result of) they can't officially apply to companies house and the exchange. They also need to present audited accounts before the name change is signed off (which I suspect they have been working on). I'd be surprised tomorrow, and I can't wait to be proved wrong here (for all out benefits) , if there is much more than an acknowledgement of the vote results and a dry update. Let's see.

Hopefully they will kick off tomorrow with an RNS and put everyone in a good mood going into the GM. Also, by holding the meeting in an easy to get to location and a reasonable late morning time, they are not trying to dodge the bullet , like certain companies I could mentioned (*cough* ALGW)

Wild_Card - They have LTD companies now so they should be able to service any contractual situation (which is why I think they were set up for that purpose) . The 'no contracts before name change' situation is being used as a bit of an excuse as how could they announce the £1m contract then as a few have pointed out.

Things that would be good to know.

1) Lead time on the name change and PR once name change has been sanctioned. Companies house and Exchange process

2) Shareholders register. Where is it?

3) Proposed structure of the board for Iconic Labs PLC

3) Contracts update and clarification of client for £1m contract. (Several in documentation stage 8 weeks ago - what happened?)

4) Stemcell business sale, any overhang from legacy now accounts should have been audited.

5) Introduce IR function for better investor interactions and comms.

If they only show up and give a quick. All proposals passed proclamation and naff off quickly I think that will go down like a lead-balloon.

I'm surprised we've seen nothing today in the way of some news as currently the silence is deafening .

Or people getting out because the 'team' have delivered s0d all?

Who knows?

The RNS today was about the only option left open to them apart from making board level cuts.

This feels like a rear-guard action now. Whenever companies start the 'pay the bills and staff with shares' malarky then you know thing are in a bad way. Kind of putting off the inevitable pending some miracle.

Good reply Wild Card.

I'll look into this.

I just hope that they see sense and do something early next week to ensure the price is higher here and they don't walk into a GM with a load of investors who are under water.

It's a simple question; Why would John Quinlan and team, with so much potential, not set up a clean shell company and eventually IPO but instead get into bed with a legacy company in a totally unrelated field with a tonne of legacy baggage inheriting a 1.4bn share circulation, amongst other things?

Why is John Quinlan, during interviews, keeps talking about 'acquisitions' when they are barely incorporated ? Where are they going to get the money for acquisitions ? Rapid growth costs money and I know just they guys that can help us.

It's worth pointing out that your can't change the name of a company until the vote has been completed and the resolution past. Then you have to apply both companies house and then the exchange amongst others.

It's not like Sefton is going to just proclaim it on the day and shout 'Let the PR and Contracts Begin' . It could be quite a while after.

Why are we waiting for the names change. Why didn't they wait before when they announced the £1m.

This is like stating we can't sell anything in the shop until we change the sign out front.

They have a limited company they could utilise for contractual purposes.

Why would you want to go into an EGM with people ask awkward questions about

1) Several contracts in 'Documentation Stage' - Weeks ago (so many clients approaching them too!!).
2) No news on restructuring or Stemcell business disposal
3) No name to that £1m contract
4) No shareholder register as promised.
5) No PR (These guys are supposed to be online marketing gurus FFS!)

Surely some news to go into that meeting with would be better than nothing. Not expecting all of it just a taster.

Listen to this again.
https://www.youtube.com/watch?v=t5ZoCH7mx-0

https://www.youtube.com/watch?v=MuZRynWkPsA&t=2s

My guess is a resignation is afoot.

Currently has a classic daily support point of 0.25. Only one indicator is showing as oversold.

Canis - They haven't invested anything. It's technically a loan. They know there is enough Mcap and juice left in the share price from 11p to be able to sell down their holding and make a tidy profit.

Look at Lanstead's past.

The BHR is not a major dependency on Phulbari. The energy requirement servicing the strategic roadmap of the GoB is.

YH - Old news.

Be careful what you lap up from the company before you regurgitate it. Just remember you probably have more shares that Tim McCarthy.

If he hasn't faith , why should you.

Doesn't say which creditors.

'2018 Fundraise
Shares in WideCells were suspended from trading on the Main Market on 3rd May 2018 shortly after the company announced it would be unable to publish its full year results for 2017 within the four month regulatory deadline. This was pending discussions over an equity fundraising, without which the company flagged it would not be able to continue as a going concern. In the meantime, WideCells announced that it accepted loans from certain directors during April 2018 of approximately £115,000 (interest free and repayable on demand after 1st July 2019) in addition to a loan of £100,000 accepted in October 2017. The 2017 results were eventually published on 5th June, with the shares being restored to trading on 11th June after the company finalised the details of the fundraise.'

http://www.alignresearch.co.uk/wp-content/uploads/2018/06/Widecells_Initiation_Align_Research_15th-June_2018.pdf

See 'Financials & Recent Developments' section.

Then why do we have someone still dumping over the last few days? Surely this should be the interim time to buy in?

Tim MCCarthy is a wage sap. He holds very few shares (the IR girl holds more than him) , so he's only interested in where the next pay packet is coming from.

He knows with the borderline nature of these results that it will be difficult organising a partnership with anyone (remember the 10 NDAs , whatever happened to those?) and the if that happens there will be a 12 months delay at least as I'm not sure with these ET results (where are the placebo numbers?_ that the FDA would entertain wasting time and energy on negotiating a new trial design. Again, what ever happened to the MAP? Whatever happened to the £2.1m that was given to Tim's other company Incanthera, which was suppose to IPO but is miles away from that too.

We've all given the man a chance but now he's taken us all for suckers. Come back in 18 months time, hopefully they'll have a news BoD and some transparency.

Worth reading the RNSs from this year.

There are debts that can be demanded from 1st July (Monday).

Nolupus - I beg to differ as the FDA have a lead time of around 12 months. It's ll academic anyway as it seems they are no where near a partnership.

Whatever happened the the much talked about MAP?